Promising microRNA study
November 28, 2016
Postdoctoral researcher Cristina Espinosa runs an experiment, November 16, 2016. The early evidence found in research at OHSU by Espinosa, Dr. Sudarshan Anand and his team is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)
Donald Sullivan
November 17, 2016
Donald Sullivan, M.D., assistant professor of medicine (hematology/medical oncology) in the OHSU School of Medicine, affiliate researcher at the OHSU Knight Cancer Institute and affiliate investigator with the Portland VA, lead the research.
(OHSU)
Study suggests brain changes for astronauts traveling to Mars
November 16, 2016
Long-term exposure to cosmic radiation could alter the brain and change behavior in astronauts bound for Mars, according to new research led by scientists at OHSU in Portland, Oregon.
Depression symptoms tied to lung cancer survival, study finds
November 01, 2016
OHSU research published in the Journal of Clinical Oncology shows that patients with lung cancer who have symptoms of depression have overall lower survival rates than those without depression symptoms.
Oregon women sought for study on the potential connection between blood cancers and heart disease
October 29, 2016
As we age, as many as 10 to 30 percent of us spontaneously carry mutations in our blood cells that put us at risk for blood cancers and heart disease. Researchers at OHSU are leading a unique study for women aged 65 and older called WEAR, or Women.
Nurse practitioners fill gap by providing timely help in recording end-of-life treatment wishes
October 21, 2016
Not all states allow nurse practitioners to make a patient’s treatment wishes part of their medical record, yet a six-year study concludes that they can improve seriously ill patients’ access to advance-care planning. Nurse practitioners often serve as the primary care provider or a member of the team caring for patients in the last months of their lives when they are most likely to seek end-of-life treatment counseling.
Mark Williams named chief strategy officer for the Knight Cancer Institute
October 21, 2016
Today OHSU announced Mark B. Williams has accepted the role of chief strategy officer for the OHSU Knight Cancer Institute. This is a new position focused on overseeing the budget and long-term financial sustainability of the Knight Cancer Institute.
NIH director Dr. Francis Collins to present the Mark O. Hatfield Lecture
October 18, 2016
CALENDAR ALERT: The Director of the National Institutes of Health, Francis S. Collins, M.D., Ph.D., will give this year’s Mark O. Hatfield Lecture.
Fiscal Year 2016 achievements in technology transfer, business development
October 13, 2016
For 11 years, TTBD has hosted an award ceremony to celebrate university accomplishments and recognize OHSU employees who’ve made significant contributions to innovation, entrepreneurship, industry partnership, patenting, and technology commercialization. Following are highlights from last night’s 2016 TTBD Awards Ceremony.
Doernbecher researchers awarded more than $9 million to fight Fanconi anemia
October 10, 2016
Thanks to a $9.9 million grant from the National Heart, Lung, and Blood Institute, a team led by Markus Grompe, M.D., director of the Oregon Stem Cell Center at OHSU and the Papé Family Pediatric Research Institute at OHSU Doernbecher Children’s Hospital, will work to understand human response to novel drug treatments that have shown promise in FA-positive animal models.